SEC Form 4 · accession 0001203311-15-000013
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David W Gryska
Director
Period of report
Apr 8, 2015
Accepted (ET)
Apr 10, 2015 · 6:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 8, 2015 | M | 5,000 | $8.38 | A | 30,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $8.38 | Apr 8, 2015 | M | 5,000 | D | — | May 15, 2019 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1These shares represent restricted stock units and will be settled in common stock upon vesting.
- F2The option vested in full on May 14, 2010.